Recently, BirdoTech has completed financing of tens of millions of US dollars. The Financing is jointly initiated by LYFE Capital and Legend Capital, followed by Dian Shi Hua Yi, Highlight Capital, Cowin Capital, CMB International and Xiamen C&D Emerging Industry Equity Investment.
Through the financing, BirdoTech will further speed up productivity construction, intensify scientific research and technical strength, create world-class platforms for catalytic screening, flow chemistry and chiral resolution, enhance the new drug regulatory service ability, construct high-end API factories, and improve the integrated service ability, aiming to continuously create higher value for customers. In the future, BirdoTech will always practice the corporate culture of "integrity, credibility, breakthrough, and innovation", remain true to the original aspiration, keep forging ahead, and cooperate with the investment institutions pursuing common value for win-win results, so as to make contributions to the great cause of human health!
Sincere thanks will be given to all BirdoTech Team as well as to Citic Securities, King & Wood Mallesons, Da Hua Certified Public Accounts, due diligence team Zhong Lun Law Firm, and Grant Thornton for their great support.
